feed,title,long_url,short_url
SeekingAlpha,Novartis sees no benefit of Adakveo for sickle cell ailment in phase 3 trial,https://seekingalpha.com/news/3929011,
SeekingAlpha,Fortinet shares slip; Mizuho cuts rating on 'elevated' challenges,https://seekingalpha.com/news/3929007,
SeekingAlpha,FTX collapse fuels more scrutiny of firms who have custody of client crypto funds,https://seekingalpha.com/news/3929009,
